Czech National Bank Increases Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Czech National Bank raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 99,060 shares of the company’s stock after acquiring an additional 6,034 shares during the period. Czech National Bank’s holdings in GE HealthCare Technologies were worth $7,745,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the company. Acadian Asset Management LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $629,000. Quest Partners LLC acquired a new position in GE HealthCare Technologies in the second quarter valued at $95,000. LPL Financial LLC raised its holdings in shares of GE HealthCare Technologies by 17.7% in the second quarter. LPL Financial LLC now owns 397,120 shares of the company’s stock valued at $30,944,000 after buying an additional 59,860 shares during the last quarter. Oppenheimer & Co. Inc. boosted its stake in shares of GE HealthCare Technologies by 27.8% during the second quarter. Oppenheimer & Co. Inc. now owns 20,716 shares of the company’s stock worth $1,614,000 after buying an additional 4,509 shares during the period. Finally, DekaBank Deutsche Girozentrale grew its holdings in shares of GE HealthCare Technologies by 28.0% during the second quarter. DekaBank Deutsche Girozentrale now owns 69,149 shares of the company’s stock worth $5,450,000 after buying an additional 15,119 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $84.13 on Wednesday. The firm has a 50 day moving average of $82.13 and a 200-day moving average of $84.27. The company has a market cap of $38.44 billion, a price-to-earnings ratio of 23.11, a PEG ratio of 2.90 and a beta of 1.11. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 12-month low of $71.31 and a 12-month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. GE HealthCare Technologies’s revenue was up .9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.99 earnings per share. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

Wall Street Analysts Forecast Growth

Several analysts have commented on GEHC shares. Stifel Nicolaus upped their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Evercore ISI increased their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Wednesday, September 18th. Finally, UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the company from $84.00 to $74.00 in a report on Thursday, September 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.